← Back to Patent Explorer
US5445832A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of microspheres made of a biodegradable polymeric material

Assignee: Debio Recherche Pharmaceutique SA
•
Filing: 1992-07-16
•
Granted: 1995-08-29
•
Expires: 2012-07-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The process is aimed at providing a composition designed for the sustained and controlled release of medicamentous peptide substances, obtained in the form of microspheres of a biodegradable polymeric material incorporating said medicamentous substance. It consists in converting first a water-soluble peptide or peptide salt into a water-insoluble peptide, respectively peptide salt. The following steps include preparing an organic-aqueous emulsion and then extracting the organic solvent in an excess of aqueous medium.

Inventors

  • 👤 Piero Orsolini
  • 👤 Frederic Heimgartner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:13
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/04; A61K38/08; A61K38/16; A61K38/17; A61K38/22; A61K38/25; A61K38/09; A61K38/18; A61K38/1808; A61K38/19; A61K38/21; A61K38/2242; A61K38/2257; A61K38/23; A61K38/26; A61K38/28; A61K38/31; A61K38/33; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K9/1682; A61K9/1694; A61P; A61P5/00; A61P5/06; A61P5/24; C; C07; C07K; C07K7/00; C07K7/04; C07K7/23

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 153 words
A process for preparing a composition for the sustained and controlled release of a medicamentous peptide substance, said medicamentous peptide substance being a natural or synthetic poly peptide comprising from about 3 to about 45 amino acids, said composition being obtained in the form of microspheres of a biodegradable polymeric organic material incorporating said medicamentous substance, comprising the steps of: (a) converting a water soluble peptide or peptide salt into a corresponding water-insoluble peptide salt selected from the group consisting of the pamoate, stearate, and palmitate of said peptide; (b) suspending said water-insoluble peptide salt in an organic solvent containing a dissolved biodegradable polymeric organic material to form a suspension; (c) dispersing said organic suspension in an aqueous medium to form an aqueous emulsion, where the aqueous medium forms the continuous phase of the emulsion; (d) transferring said emulsion into an excess of an aqueous medium, and separating microspheres from the liquid phase.
Claim 2
Dependent Claim 153 words
A process for preparing a composition for the sustained and controlled release of a medicamentous peptide substance, said medicamentous peptide substance being a natural or synthetic poly peptide comprising from about 3 to about 45 amino acids, said composition being obtained in the form of microspheres of a biodegradable polymeric organic material incorporating said medicamentous substance, comprising the steps of: (a) converting a water soluble peptide or peptide salt into a corresponding water-insoluble peptide salt selected from the group consisting of the pamoate, stearate, and palmitate of said peptide; (b) suspending said water-insoluble peptide salt in an organic solvent containing a dissolved biodegradable polymeric organic material to form a suspension; (c) dispersing said organic suspension in an aqueous medium to form an aqueous emulsion, where the aqueous medium forms the continuous phase of the emulsion; (d) transferring said emulsion into an excess of an aqueous medium, and separating microspheres from the liquid phase.
Claim 3
Dependent Claim 26 words
A process according to claim 1 wherein before transferring said emulsion into an excess of aqueous medium, a partial evaporation of organic medium is carried out.
Claim 4
Dependent Claim 61 words
A process according to one of claims 1 or 2, wherein the medicamentous substance is selected from the group consisting of oxytocin, vasopressin, corticotrophin, calcitonin, epidermal growth factor (EGF), prolactin, inhibitin, interferon, somatoststin, insulin, glucagon, auricular natriuretic factor (ANF), endorphin, a renin inhibitor, luteinizing hormone-releasing hormone (LHRH), growth hormone releasing hormone (GHRH), peptide T, their synthetic analogues and their synthetic homologues.
Claim 5
Dependent Claim 55 words
A process according to one of claims 1 or 2 wherein the medicamentous substance is selected from the group consisting of LHRH, somatostatin, one of their synthetic analogues or homologues, ##STR3## Ac-DNal-DpCl-Phe-DPal-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH 2 , (pyro) Glu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 , (pyro) Glu-His-Trp-Ser-Tyr-D-Phe-Leu-Arg-Pro-Gly-NH 2 , (pyro) Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-Gly-NHR 1 and (pyro) Glu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-Gly- NHR 1 , (R 1 =lower alkyl).
Claim 6
Dependent Claim 39 words
A process according to one of claims 1 or 2 wherein the biodegradable polymeric material is selected from the group consisting of polylactides, polyglycolides, copolymers of lactic and glycolic acids, polyesters, polyalkylene fumarate, polyalkylene succinate, polyorthoesters, polyacetals and polyanhydrides.
Claim 7
Dependent Claim 49 words
A process according to claim 5 wherein the polymeric material is a copolymer of lactic and glycolic acids, wherein the molar ratio of lactic to glycolic residues, respectively, ranges from 45:55 to 90:10, and wherein the lactic acid residues may be in either the L or D, L configuration.
Claim 8
Dependent Claim 28 words
A process according to claim 6, wherein the polyalkylene fumarate or polyalkylene succinate is selected from the group consisting of poly-1,4-butylene--succinates, poly-2,3-butylene succinates poly-1,4-butylene fumarates and poly-2,3-butylene fumarates.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-08-28 1999-02-27 1999-08-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-08-28 2003-02-27 2003-08-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-08-28 2007-02-27 2007-08-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag